Phase I Study of SP-3164 in Relapsed or Refractory Non-Hodgkin's Lymphoma

Condition:   Lymphoma, Non-Hodgkin's, Adult Intervention:   Drug: SP-3164 Sponsor:   Salarius Pharmaceuticals, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials